Back to Search Start Over

Optimal treatment for small HCC

Authors :
Xiao Wu
Ryan Peter Lokken
Neil Mehta
Source :
JHEP Reports, Vol 5, Iss 8, Pp 100781- (2023)
Publication Year :
2023
Publisher :
Elsevier, 2023.

Abstract

Summary: Hepatocellular carcinoma (HCC) remains the most common form of liver cancer, accounting for 90% of all primary liver cancers. Up to 30% of HCC cases could be small (2–3 cm in diameter) at the time of diagnosis with advances in imaging techniques and surveillance programmes. Treating patients with early-stage HCC can be complex and often requires interdisciplinary care, owing to the wide and increasing variety of treatment options, which include liver resection, liver transplantation, and various locoregional therapies offered by interventional radiology and radiation oncology. Decisions regarding the optimal management strategy for a patient involve many considerations, including patient- and tumour-specific characteristics, as well as socioeconomic factors. In this review, we aim to comprehensively summarise the commonly used therapies for single, small HCC (

Details

Language :
English
ISSN :
25895559
Volume :
5
Issue :
8
Database :
Directory of Open Access Journals
Journal :
JHEP Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.62f958833824296bee716ac91ea787f
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jhepr.2023.100781